Literature DB >> 19304895

Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses.

Mingcai Li1, Xiaojin Liu, Yanchun Zhou, Shao Bo Su.   

Abstract

IFN-lambdas, including IFN-lambda1, IFN-lambda2, and IFN-lambda3, also known as IL-29, IL-28A, or IL-28B, are a newly described group of cytokines distantly related to the type I IFNs and IL-10 family members. The IFN-lambdaR complex consists of a unique ligand-binding chain, IFN-lambdaR1 (also designated IL-28Ralpha), and an accessory chain, IL-10R2, which is shared with receptors for IL-10-related cytokines. IFN-lambdas signal through the IFN-lambdaR and activate pathways of JAK-STATs and MAPKs to induce antiviral, antiproliferative, antitumor, and immune responses. In this review, we summarize recent findings about the biology of IFN-lambdas and their pathophysiological roles in viral infection, cancer, and immune responses of the innate and adaptive arms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19304895     DOI: 10.1189/jlb.1208761

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  60 in total

Review 1.  Structure and function of interleukin-22 and other members of the interleukin-10 family.

Authors:  Daniela Barretto Barbosa Trivella; José Ribamar Ferreira-Júnior; Laure Dumoutier; Jean-Christophe Renauld; Igor Polikarpov
Journal:  Cell Mol Life Sci       Date:  2010-05-08       Impact factor: 9.261

2.  T cell cytokine signatures: Biomarkers in pediatric multiple sclerosis.

Authors:  Cather M Cala; Carson E Moseley; Chad Steele; Sarah M Dowdy; Gary R Cutter; Jayne M Ness; Tara M DeSilva
Journal:  J Neuroimmunol       Date:  2016-04-30       Impact factor: 3.478

3.  Genetic Variants in Interleukin-28B Are Associated with Diabetes and Diabetes-Related Complications in Patients with Chronic Hepatitis C Virus Infection.

Authors:  Fasiha Kanwal; Donna L White; Li Jiao; Shahriar Tavakoli-Tabasi; Shubhada Sansgiry; David J Ramsey; Jill Kuzniarek; Andrew Spiegelman; Hashem B El-Serag
Journal:  Dig Dis Sci       Date:  2015-02-08       Impact factor: 3.199

4.  Interferon lambda inhibits herpes simplex virus type I infection of human astrocytes and neurons.

Authors:  Jieliang Li; Shuxian Hu; Lin Zhou; Li Ye; Xu Wang; Jie Ho; Wenzhe Ho
Journal:  Glia       Date:  2010-09-27       Impact factor: 7.452

5.  Standardization of human IL-29 (IFN-λ1): establishment of a World Health Organization international reference reagent for IL-29 (IFN-λ1).

Authors:  Anthony Meager; Alan Heath; Paula Dilger; Kathryn Zoon; Meenu Wadhwa
Journal:  J Interferon Cytokine Res       Date:  2014-06-23       Impact factor: 2.607

Review 6.  The airway epithelium: soldier in the fight against respiratory viruses.

Authors:  Marjolaine Vareille; Elisabeth Kieninger; Michael R Edwards; Nicolas Regamey
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

7.  Comparison of antiviral activity of lambda-interferons against HIV replication in macrophages.

Authors:  Yizhong Wang; Jieliang Li; Xu Wang; Yu Zhou; Ting Zhang; Wenzhe Ho
Journal:  J Interferon Cytokine Res       Date:  2014-09-30       Impact factor: 2.607

8.  Modulation of the function of dendritic cells in adolescents with chronic HBV infection by IFN-λ1.

Authors:  Haihua Sun; Lijuan Bi; Junying Zhou; Dongfang Zhou; Yinghui Liu; Guohua Jin; Wenzhao Yan
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

9.  Type III interferons are expressed by Coxsackievirus-infected human primary hepatocytes and regulate hepatocyte permissiveness to infection.

Authors:  K Lind; E Svedin; R Utorova; V M Stone; M Flodström-Tullberg
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

Review 10.  Genetic variants at the IFNL3 locus and their association with hepatitis C virus infections reveal novel insights into host-virus interactions.

Authors:  Sreedhar Chinnaswamy
Journal:  J Interferon Cytokine Res       Date:  2014-02-20       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.